A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep).
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Capecitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 09 Nov 2015 New trial record